Intuitive Surgical Faces Increased Competition from Medtronic's New Robot
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2026
0mins
Source: NASDAQ.COM
Intuitive Surgical Inc's stock has dropped 3.00% and hit a 20-day low amid increased competition in the surgical robotics market.
The company has installed 11,395 da Vinci surgical systems globally, reflecting a 12% year-over-year increase. However, Medtronic has recently launched its Hugo surgical robot, which could intensify market competition and pose challenges for Intuitive Surgical's growth. Investors are advised to be cautious due to the high P/E ratio of 55 and the recent volatility in stock prices, which have fallen over 20% from their 52-week high.
This competitive landscape may impact Intuitive Surgical's market share and revenue growth, making it essential for the company to innovate and maintain its leadership in robotic-assisted surgeries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ISRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ISRG
Wall Street analysts forecast ISRG stock price to rise
20 Analyst Rating
16 Buy
4 Hold
0 Sell
Strong Buy
Current: 418.820
Low
575.00
Averages
637.32
High
740.00
Current: 418.820
Low
575.00
Averages
637.32
High
740.00
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Three Undervalued Growth Stocks to Consider
- Robotic Surgery Market Outlook: Intuitive Surgical's stock has fallen 27% in 2026, and while it leads the robotic-assisted surgery market, its high valuation has pressured the stock, currently trading at a forward P/E of about 40, with significant growth potential as the global surgical robot market is projected to reach $18.5 billion by 2033.
- Telecom Industry Resilience: T-Mobile's stock is down 13%, yet it reported an 11% revenue growth in Q1 2026 despite fears of competition from SpaceX, with a forward P/E of 17, below the S&P 500 average of 22, indicating strong competitive positioning in the telecom sector.
- Credit Card Industry Leader: Mastercard's Q1 2026 revenue reached $8.4 billion, up 16% year-over-year, with profits surging 18% to $3.9 billion; despite concerns over potential caps on credit card interest rates, its business remains robust, trading at a forward P/E of 24, lower than its historical average, making it a solid investment choice.
- Investment Opportunity Analysis: Although Intuitive Surgical was not recommended by Motley Fool Stock Advisor, its strong demand in the healthcare sector and future growth potential make it a stock to watch, especially given its current undervaluation, presenting a compelling long-term investment opportunity.
See More
Three Quality Growth Stocks Hit New Lows
- Intuitive Surgical Performance: Intuitive Surgical's stock has fallen 27% in 2026, and despite being a leader in the robotic-assisted surgery market, its high valuation has pressured the stock, currently trading at a P/E of about 50 and a forward P/E of 40, indicating potential for long-term investment.
- Market Growth Potential: The global surgical robot market was valued at $6.6 billion in 2022 and is projected to grow to $18.5 billion by 2033, suggesting that while the market is still small, the growth prospects could yield significant returns for investors.
- T-Mobile Competitive Edge: T-Mobile's stock has dropped 13% this year, but despite intense competition and market concerns, it reported an impressive revenue growth of around 11% in Q1 2026, demonstrating strong market adaptability and customer satisfaction.
- Mastercard Financial Performance: Mastercard's revenue reached $8.4 billion in Q1 2026, up 16% year-over-year, with profits surging 18% to $3.9 billion, showcasing robust growth potential despite concerns over interest rate caps, making it a compelling investment opportunity.
See More
Robotic Surgery Pioneer Intuitive Surgical Shares Plummet
- Strong Revenue Growth: In Q1 2026, Intuitive Surgical reported revenue of $2.77 billion, a 23% year-over-year increase, indicating robust growth in the surgical robotics market despite competitive pressures.
- Market Share Stability: The company placed 431 da Vinci systems this quarter, up 17% from 367 a year earlier, with an installed base growing 12% to 11,395 systems, reflecting strong market demand.
- Competitive Pressure Analysis: Although growth in the Chinese market lagged behind the corporate average and domestic competitors gained market share, Intuitive's global procedure volume still grew by 20%, demonstrating its solid market position.
- Optimistic Future Outlook: Management raised its full-year guidance, now forecasting da Vinci procedure growth of 13.5% to 15.5%, indicating that despite potential threats from emerging competitors like OpenAI, the company's core competencies remain strong.
See More
Intuitive Surgical Shares Plummet Amid Competition and AI Concerns
- Stock Performance Decline: Intuitive Surgical's shares have plummeted approximately 26% in 2026, trading near a 52-week low and losing nearly a third of their value since peaking above $600 in January, indicating significant market concerns about future growth.
- Strong Revenue Growth: The company reported first-quarter revenue of $2.77 billion, a 23% year-over-year increase, outpacing the 17% growth in surgical procedures, demonstrating its competitive strength, with recurring revenue now accounting for 86% of total sales.
- Increased Market Competition: While competition from Chinese surgical robots is rising, Intuitive placed 431 da Vinci systems in the U.S. and 117 in Europe last quarter, indicating robust demand and solidifying its position in the global market despite slower growth in China.
- AI Threat Overstated: Concerns about OpenAI's entry into robotics may be exaggerated, as Intuitive Surgical's established dominance in soft-tissue surgery, backed by extensive clinical data, positions it well against potential competition, with the CEO highlighting the company's advantages in its AI roadmap.
See More
Analysis of VUG ETF's 52-Week Price Fluctuations
- Price Range Analysis: The VUG ETF's 52-week low is $69.27 per share, with a high of $90.60, while the latest trade stands at $88.56, indicating a relatively strong performance close to its peak, which may attract more investor interest.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide valuable insights for investors, helping to assess market trends and potential buy or sell opportunities, thereby optimizing investment decisions.
- ETF Unit Trading Mechanism: ETFs trade like stocks, where investors are actually buying and selling 'units' that can be created or destroyed based on investor demand, reflecting market changes and impacting liquidity and price volatility.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing significant inflows (new units created) or outflows (old units destroyed), as these liquidity shifts can affect the performance of individual stocks held within the ETFs and influence overall market sentiment.
See More
Investment Insights on Intuitive Surgical
- Market Trend Analysis: In the latest Motley Fool Scoreboard episode, analysts discussed market trends for Intuitive Surgical, noting that while the company did not make the recommended top 10 stocks list, it still attracts investor interest, reflecting its potential in the medical technology sector.
- Investment Return Comparison: The Motley Fool Stock Advisor boasts an average return of 983%, significantly outperforming the S&P 500's 212%, indicating that even though Intuitive Surgical is not recommended, its market performance remains noteworthy, prompting investors to carefully assess its future growth potential.
- AI and Market Outlook: The episode highlighted the potential for AI to create the world's first trillionaire, suggesting opportunities for Intuitive Surgical in the intersection of medical technology and AI, which investors should monitor for innovation and development.
- Investor Community Engagement: Motley Fool encourages investors to join its community to share investment experiences and gain the latest market insights, and although Intuitive Surgical is not on the recommended list, its technology and market position continue to spark widespread discussion.
See More
Three Undervalued Growth Stocks to Consider
- Robotic Surgery Market Outlook: Intuitive Surgical's stock has fallen 27% in 2026, and while it leads the robotic-assisted surgery market, its high valuation has pressured the stock, currently trading at a forward P/E of about 40, with significant growth potential as the global surgical robot market is projected to reach $18.5 billion by 2033.
- Telecom Industry Resilience: T-Mobile's stock is down 13%, yet it reported an 11% revenue growth in Q1 2026 despite fears of competition from SpaceX, with a forward P/E of 17, below the S&P 500 average of 22, indicating strong competitive positioning in the telecom sector.
- Credit Card Industry Leader: Mastercard's Q1 2026 revenue reached $8.4 billion, up 16% year-over-year, with profits surging 18% to $3.9 billion; despite concerns over potential caps on credit card interest rates, its business remains robust, trading at a forward P/E of 24, lower than its historical average, making it a solid investment choice.
- Investment Opportunity Analysis: Although Intuitive Surgical was not recommended by Motley Fool Stock Advisor, its strong demand in the healthcare sector and future growth potential make it a stock to watch, especially given its current undervaluation, presenting a compelling long-term investment opportunity.
See More
Three Quality Growth Stocks Hit New Lows
- Intuitive Surgical Performance: Intuitive Surgical's stock has fallen 27% in 2026, and despite being a leader in the robotic-assisted surgery market, its high valuation has pressured the stock, currently trading at a P/E of about 50 and a forward P/E of 40, indicating potential for long-term investment.
- Market Growth Potential: The global surgical robot market was valued at $6.6 billion in 2022 and is projected to grow to $18.5 billion by 2033, suggesting that while the market is still small, the growth prospects could yield significant returns for investors.
- T-Mobile Competitive Edge: T-Mobile's stock has dropped 13% this year, but despite intense competition and market concerns, it reported an impressive revenue growth of around 11% in Q1 2026, demonstrating strong market adaptability and customer satisfaction.
- Mastercard Financial Performance: Mastercard's revenue reached $8.4 billion in Q1 2026, up 16% year-over-year, with profits surging 18% to $3.9 billion, showcasing robust growth potential despite concerns over interest rate caps, making it a compelling investment opportunity.
See More
Robotic Surgery Pioneer Intuitive Surgical Shares Plummet
- Strong Revenue Growth: In Q1 2026, Intuitive Surgical reported revenue of $2.77 billion, a 23% year-over-year increase, indicating robust growth in the surgical robotics market despite competitive pressures.
- Market Share Stability: The company placed 431 da Vinci systems this quarter, up 17% from 367 a year earlier, with an installed base growing 12% to 11,395 systems, reflecting strong market demand.
- Competitive Pressure Analysis: Although growth in the Chinese market lagged behind the corporate average and domestic competitors gained market share, Intuitive's global procedure volume still grew by 20%, demonstrating its solid market position.
- Optimistic Future Outlook: Management raised its full-year guidance, now forecasting da Vinci procedure growth of 13.5% to 15.5%, indicating that despite potential threats from emerging competitors like OpenAI, the company's core competencies remain strong.
See More
Intuitive Surgical Shares Plummet Amid Competition and AI Concerns
- Stock Performance Decline: Intuitive Surgical's shares have plummeted approximately 26% in 2026, trading near a 52-week low and losing nearly a third of their value since peaking above $600 in January, indicating significant market concerns about future growth.
- Strong Revenue Growth: The company reported first-quarter revenue of $2.77 billion, a 23% year-over-year increase, outpacing the 17% growth in surgical procedures, demonstrating its competitive strength, with recurring revenue now accounting for 86% of total sales.
- Increased Market Competition: While competition from Chinese surgical robots is rising, Intuitive placed 431 da Vinci systems in the U.S. and 117 in Europe last quarter, indicating robust demand and solidifying its position in the global market despite slower growth in China.
- AI Threat Overstated: Concerns about OpenAI's entry into robotics may be exaggerated, as Intuitive Surgical's established dominance in soft-tissue surgery, backed by extensive clinical data, positions it well against potential competition, with the CEO highlighting the company's advantages in its AI roadmap.
See More
Analysis of VUG ETF's 52-Week Price Fluctuations
- Price Range Analysis: The VUG ETF's 52-week low is $69.27 per share, with a high of $90.60, while the latest trade stands at $88.56, indicating a relatively strong performance close to its peak, which may attract more investor interest.
- Technical Analysis Tool: Comparing the latest share price to the 200-day moving average can provide valuable insights for investors, helping to assess market trends and potential buy or sell opportunities, thereby optimizing investment decisions.
- ETF Unit Trading Mechanism: ETFs trade like stocks, where investors are actually buying and selling 'units' that can be created or destroyed based on investor demand, reflecting market changes and impacting liquidity and price volatility.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs helps identify those experiencing significant inflows (new units created) or outflows (old units destroyed), as these liquidity shifts can affect the performance of individual stocks held within the ETFs and influence overall market sentiment.
See More
Investment Insights on Intuitive Surgical
- Market Trend Analysis: In the latest Motley Fool Scoreboard episode, analysts discussed market trends for Intuitive Surgical, noting that while the company did not make the recommended top 10 stocks list, it still attracts investor interest, reflecting its potential in the medical technology sector.
- Investment Return Comparison: The Motley Fool Stock Advisor boasts an average return of 983%, significantly outperforming the S&P 500's 212%, indicating that even though Intuitive Surgical is not recommended, its market performance remains noteworthy, prompting investors to carefully assess its future growth potential.
- AI and Market Outlook: The episode highlighted the potential for AI to create the world's first trillionaire, suggesting opportunities for Intuitive Surgical in the intersection of medical technology and AI, which investors should monitor for innovation and development.
- Investor Community Engagement: Motley Fool encourages investors to join its community to share investment experiences and gain the latest market insights, and although Intuitive Surgical is not on the recommended list, its technology and market position continue to spark widespread discussion.
See More
